reports
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 10 new employees. In accordance with Nasdaq Listing Rule 5635(c)(4), on December 6, 2023, the Compensation and Human Capital Committee of NanoString’s Board of Directors approved the grant of, in the aggregate, 34,925 restricted stock units, or RSUs, as material inducements to the 10 employees entering into employment with NanoString. One-third of the R...
NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Health...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 42nd annual J.P. Morgan healthcare conference, being held January 8-11, 2024. Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, January 10, at 5:15pm ET. Interested parties can access the live webcast from the investor section of the company’s website at . The webcast replay will be available one hour after the conc...
NanoString Comments on Delaware District Court Verdict
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on the November 17th verdict of a jury in the U.S. District Court for the District of Delaware finding that NanoString GeoMx® Digital Spatial Profiler products infringe patents licensed to 10x Genomics and awarding approximately $31 million in damages, consisting of approximately $25 million of lost profits and a $6 million royalty. “We respectfully disagree with the jury’s verdict, which we will seek to have overturned or amend...
NanoString to Webcast Presentations from Upcoming Healthcare Conferenc...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. Stifel 2023 Healthcare Conference Tuesday, November 14th Tom Bailey, NanoString’s chief financial officer, and Doug Farrell, VP of Investor Relations, will participate in a fireside discussion hosted by Stifel analyst Dan Arias at 9:45am ET. Jefferies London Healthcare Conference Thursday, November 16th Tom Bailey, Nano...
NanoString Technologies Releases Operating Results for Third Quarter o...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter ended September 30, 2023. The Company also announced it had reached agreement with holders to exchange approximately $216 million, or 94%, principal amount of its Convertible Notes for new Senior Secured Notes due September 1, 2026 and common stock warrants. “The last few months have been extraordinarily productive for our team. During the third quarter, we delivered record revenue whi...
NanoString Provides Preliminary Financial and Operational Highlights f...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the third quarter ended September 30, 2023, as well as a reorganization designed to accelerate the Company’s path to profitability. “Our teams delivered strong revenue results for the third quarter, with preliminary results exceeding consensus estimates and the high end of our guidance range,” said Brad Gray, President and CEO of NanoString. “In addition, we began importan...
NanoString Comments on Unified Patent Court Order
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on today’s order from the European Unified Patent Court (UPC) granting a preliminary injunction effective immediately in 17 Member States of the European Union against NanoString’s CosMx™ Spatial Molecular Imager (SMI) products for RNA detection in NanoString’s ongoing patent dispute with 10x Genomics and Harvard: “We are disappointed with today’s decision by the UPC and will immediately appeal the preliminary injunction in the ...
NanoString Expands Partnerships with Contract Research Organizations M...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, announced today three new Contract Research Organization (CRO) CosMxTM Spatial Molecular Imager partnerships. Macrogen, Propath UK, and Sirona Dx offer global biopharma customers new access to CosMx™ SMI technology for translational drug development. These specialty CROs provide biomarker testing services for drug developers and academic research institutions. “NanoString is honored to partner with these leading CROs and accelerate access ...
NanoString to Webcast Presentations from Upcoming Healthcare Conferenc...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. Morgan Stanley 21st Annual Global Heathcare Conference Tuesday, September 12th Brad Gray, NanoString’s chief executive officer, will participate in a fireside discussion at 5:00pm ET hosted by Morgan Stanley analyst Tejas Savant. Baird Conference Wednesday, September 13th Brad Gray, NanoString’s chief executive officer,...
NanoString Appoints Todd Garland as Chief Commercial Officer
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for discovery and translational research, today announced that Todd Garland has been appointed Chief Commercial Officer, effective August 28, 2023. This press release features multimedia. View the full release here: NanoString Appoints Todd Garland as Chief Commercial Officer (Photo: Business Wire) Mr. Garland is a senior executive with more than 25 years of experience in healthcare and life sciences technologies that serve customers in the discovery, translational and clinical markets. Mo...
NanoString Platforms Advance Groundbreaking Studies of Immune Response...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced today that a team of globally renowned researchers utilized two NanoString platforms, the nCounter® Analysis System and GeoMx® Digital Spatial Profiler, to decode the immune response following the transplantation of genetically modified pig kidneys into humans. The groundbreaking study featured in the August issue and an accompanying commentary of produced fundamental new data on the first pig-to-human organ transplants. Insight ...
NanoString to Webcast Presentations from Upcoming Healthcare Conferenc...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. 43rd Annual Canaccord Global Growth Conference Wednesday, August 9th Tom Bailey, NanoString’s chief financial officer, and Doug Farrell, VP of Investor Relations, will participate in a fireside discussion hosted by Canaccord Genuity analyst Kyle Mikson at 12:30pm ET. UBS Medtech, Tools and Genomics Summit Tuesday, Augus...
NanoString Technologies Releases Operating Results for Second Quarter ...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter ended June 30, 2023. “Strong growth in our spatial biology business and continued durability in our nCounter business helped us generate record revenue during the second quarter,” said Brad Gray, President and CEO of NanoString. “We expect to continue to benefit from substantial CosMx instrument order backlog through the back half of the year and into 2024, providing visibility into r...
Delaware District Court Permits NanoString’s Counterclaims that 10x Ge...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, provided comments on yesterday’s order of the United States District Court for the District of Delaware in NanoString’s patent litigation with 10x Genomics and President and Fellows of Harvard College. In its order, the Court granted NanoString’s motion to add new counterclaims for antitrust and unfair competition violations as well as the affirmative defense of “unclean hands” by 10x and Harvard. The ruling relates to NanoString’s claim tha...
NanoString Provides Preliminary Financial and Operational Highlights f...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the second quarter ended June 30, 2023. “We are excited to report that our teams delivered strong preliminary revenue results for the second quarter, with preliminary results exceeding consensus estimates and the upper end of our guidance ranges,” said Brad Gray, President and CEO of NanoString. “Customers are focused on the potential for spatial analysis to advance scienc...
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 23 new employees. In accordance with Nasdaq Listing Rule 5635(c)(4), on June 27, 2023, the Compensation and Human Capital Committee of NanoString’s Board of Directors granted, in the aggregate, 207,017 restricted stock units, or RSUs, to 23 employees as material inducements to their entrance into employment with NanoString. One-third of the RSUs vest on...
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 23 new employees. In accordance with Nasdaq Listing Rule 5635(c)(4), on June 6, 2023, the Compensation and Human Capital Committee of NanoString’s Board of Directors approved the grant of, in the aggregate, 159,410 restricted stock units, or RSUs, as material inducements to the 23 employees entering into employment with NanoString. One-third of the RSUs...
Acrobat Genomics, NanoString, and Illumina Accelerator Collaborate wit...
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Acrobat Genomics, NanoString Technologies, Inc. (NASDAQ:NSTG), and the Illumina Accelerator announced today their collaboration with Stanford Medicine to discover new drug targets for gene editing-based therapeutics using GeoMx® Digital Spatial Profiling (DSP) technology. This collaboration aims to improve treatment options for patients suffering from interstitial lung diseases, such as idiopathic pulmonary fibrosis. NanoString’s GeoMx DSP is a powerful spatial biology platform that enables researchers to uncover intricate interactions between cells and...
- Jonathan Moreland
MASI MASIMO CORPORATION
TCBI TEXAS CAPITAL BANCSHARES INC.
RYAM RAYONIER ADVANCED MATERIALS INC
NSTG NANOSTRING TECHNOLOGIES
GCO GENESCO INC.
CAPL CROSSAMERICA PARTNERS LP
BOH BANK OF HAWAII CORPORATION
BIG BIG LOTS INC.
ALGN ALIGN TECHNOLOGY INC.
ABR ARBOR REALTY TRUST INC.
SAFT SAFETY INSURANCE GROUP INC.
EVRI EVERI HOLDINGS INC.
ADC AGREE REALTY CORPORATION
ET ENERGY TRANSFER L.P.
NSA NATIONAL STORAGE AFFILIATES TRUST
OVLY OAK VALLEY BANCORP
FBK FB FINANCIAL CORPORATION
NNBR NN
CNX INC.
PRPL CONSOL ENERGY INC.
DOMO PURPLE INNOVATION
HHC INC.
INVA DOMO INCORPORATED
SAFE THE HOWARD HUGHES CORPORATION
BW INOVA TECH
PINE SAFEHOLD INC.
CMCT BABCOCK & WILCOX ENTERPRISES
DHC ALPINE INCOME PROPERTY TRUST
TCRR CIM COMMERCIAL TRUST CORPORATION
ORCC DIVERSIFIED HEALTHCARE TRUST
LYRA TCR2 THERAPEUTICS INC.
CPE OWL ROCK CAPITAL CORP
ADV LYRA THERAPEUTICS
ANNX INC.
ABCL CALLON PETROLEUM
DRVN ADVANTAGE SOLUTIONS INC (A)
NRGX ANNEXON
RXDX ABCELLERA BIOLOGICS
GEG DRIVEN BRANDS HOLDINGS
LFMD PIMCO ENERGY & TACTICAL CREDIT OPPORTUNITIES FUND
AUID PROMETHEUS BIOSCIENCES
EMO GREAT ELM GROUP INC
LIFEMD
INC.
IPSIDY INC.
CLEARBRIDGE ENERGY MLP OPPORTUNITY FUND INC.
Owkin Powers a New Era in Oncology Research with MOSAIC – An Unprecede...
PARIS & SEATTLE--(BUSINESS WIRE)-- Owkin, Nanostring (NASDAQ:NSTG), and world-leading cancer research institutions University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander-Universität Erlangen-Nürnberg, and Charité - Universitätsmedizin Berlin are launching (Multi Omic Spatial Atlas In Cancer) at the American Society of Clinical Oncology’s annual meeting (booth #4037). MOSAIC is a landmark $50 million project to revolutionize cancer research through the use of spatial omics, a set of cutting-edge technologies that offer unprecedented inf...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.